SNNLive: NanoBiotech Pharma, Inc.
SNNLive spoke with Gary Mezo, Chairman and CEO of NanoBiotech Pharma, Inc. at Biotech Week 2014 in San Francisco, CA.
SNNLive spoke with Gary Mezo, Chairman and CEO of NanoBiotech Pharma, Inc. at Biotech Week 2014 in San Francisco, CA.
NanobacTX killing Nanobacteria (aka CNPs, NPs or Calcifying Nanoparticles) in pure culture. Nanobacteria are responsible for the development of the pathological calcification, inflammation and amyloid soft plaque in Coronary Artery Disease (CAD), Atherosclerosis, kidney stones and tissue calcification.
FOX NEWS REPORT on our research and development of NanobacTX at NanoBiotech Pharma. Nanobacteria is the infectious cause of coronary artery calcification and heart disease. Heart Disease is a treatable infection.